Aurora Cannabis (ACB) Non-Current Debt (2019 - 2026)

Aurora Cannabis (ACB) posted quarterly Non-Current Debt of $363144.4 for Q1 2026, down 98.92% year-on-year from $33.5 million in Q1 2025, and down 97.46% on a QoQ basis from $14.3 million in Q4 2025.

Aurora Cannabis (ACB) Non-Current Debt (2019 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Non-Current Debt for 8 consecutive years, with $363144.4 the latest figure, recorded in Q1 2026.

  • Quarterly Non-Current Debt fell 98.92% year-over-year to $363144.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $363144.4 (down 98.92% YoY) and the FY2026 annual result came in at $360357.6, down 98.96% from the prior year.
  • Non-Current Debt retreated to $363144.4 in Q1 2026 per ACB's latest filing, from $14.3 million in the prior quarter.
  • Over the last five years, Non-Current Debt for ACB reached as high as $156.4 million in Q2 2023 and fell as low as $96316.0 in Q1 2022.
  • A 5-year average of $53.1 million and a median of $35.5 million in 2023 frame the typical range for Non-Current Debt.
  • Annual changes were most pronounced in 2023 — Non-Current Debt jumped 155667.78% — and 2026, when it tumbled 98.92%.
  • Year by year, Non-Current Debt stood at $36.8 million in 2022, then surged by 180.7% to $103.3 million in 2023, then decreased by 2.28% to $101.0 million in 2024, then plunged by 85.85% to $14.3 million in 2025, then plunged by 97.46% to $363144.4 in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $363144.4, $14.3 million, and $14.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn 363,144.43

Historic Data

Download Data
DateValue
Mar 31, 2026 363,144.43
Dec 31, 2025 14.29 Mn
Sep 30, 2025 14.26 Mn
Jun 30, 2025 35.52 Mn
Mar 31, 2025 33.52 Mn
Dec 31, 2024 100.98 Mn
Sep 30, 2024 100.97 Mn
Jun 30, 2024 102.10 Mn
Mar 31, 2024 3.63 Mn
Dec 31, 2023 103.34 Mn
Sep 30, 2023 127.01 Mn
Jun 30, 2023 156.38 Mn
Mar 31, 2023 35.54 Mn
Dec 31, 2022 36.82 Mn
Sep 30, 2022 37.38 Mn
Jun 30, 2022 100,395.60
Mar 31, 2022 96,316.00
Dec 31, 2021 94,406.99
Sep 30, 2021 89,768.25
Jun 30, 2021 84,606.82